Cart (0 Items)
Your cart is currently empty.
View ProductsRozanolixizumab Biosimilar – Anti-FCGRT mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Rozanolixizumab Biosimilar - Anti-FCGRT mAb - Research Grade |
|---|---|
| Source | CAS 1584645-37-3 |
| Species | Chimeric,Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Rozanolixizumab,UCB-7665,FCGRT,anti-FCGRT |
| Reference | PX-TA1433 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Rozanolixizumab Biosimilar - Anti-FCGRT mAb - Research Grade
General information on Anti-FCGRT[Homo sapiens] (Rozanolixizumab) Monoclonal Antibody
Rozanolixizumab is investigated in the treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Related products
Antigen
Human FCGRT-FCRN recombinant protein
PX-P6195 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.